KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Boston Scientific (BSX) over the last 6 years, with Q4 2025 value amounting to $50.0 million.

  • Boston Scientific's Change in Inventory rose 20869.57% to $50.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $188.0 million, marking a year-over-year decrease of 1754.39%. This contributed to the annual value of $188.0 million for FY2025, which is 1754.39% down from last year.
  • Latest data reveals that Boston Scientific reported Change in Inventory of $50.0 million as of Q4 2025, which was up 20869.57% from $94.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Change in Inventory high stood at $215.0 million for Q3 2021, and its period low was -$65.0 million during Q2 2025.
  • In the last 5 years, Boston Scientific's Change in Inventory had a median value of $94.5 million in 2022 and averaged $87.1 million.
  • Per our database at Business Quant, Boston Scientific's Change in Inventory soared by 71428.57% in 2021 and then tumbled by 17796.61% in 2024.
  • Over the past 5 years, Boston Scientific's Change in Inventory (Quarter) stood at $31.0 million in 2021, then surged by 48.39% to $46.0 million in 2022, then rose by 28.26% to $59.0 million in 2023, then plummeted by 177.97% to -$46.0 million in 2024, then skyrocketed by 208.7% to $50.0 million in 2025.
  • Its Change in Inventory was $50.0 million in Q4 2025, compared to $94.0 million in Q3 2025 and -$65.0 million in Q2 2025.